DURALOC OPTION CERAMIC HIP SYSTEM

FDA Premarket Approval P040023

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the duraloc option ceramic hip system. The device is indicated for non-cemented use in primary total hip arthroplasty in skeletally mature patients with non-inflammatory degenerative joint disease (nidjd) such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and post-traumatic arthritis.

DeviceDURALOC OPTION CERAMIC HIP SYSTEM
Generic NameProsthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented
ApplicantDEPUY ORTHOPAEDICS, INC.
Date Received2004-05-04
Decision Date2005-05-03
Notice Date2006-12-20
PMAP040023
SupplementS
Product CodeMRA 
Docket Number06M-0512
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address DEPUY ORTHOPAEDICS, INC. 700 Orthopaedic Drive warsaw, IN 46581-0988
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P040023Original Filing
S025 2012-10-25 30-day Notice
S024 2012-08-03 Special (immediate Track)
S023
S022 2012-05-18 30-day Notice
S021 2012-04-18 Normal 180 Day Track No User Fee
S020 2012-03-27 30-day Notice
S019 2011-11-09 Special (immediate Track)
S018 2011-09-16 Real-time Process
S017
S016 2009-12-11 135 Review Track For 30-day Notice
S015 2009-12-02 135 Review Track For 30-day Notice
S014 2009-10-19 Normal 180 Day Track No User Fee
S013 2008-11-26 30-day Notice
S012 2008-11-18 Normal 180 Day Track No User Fee
S011 2008-08-19 135 Review Track For 30-day Notice
S010 2007-10-12 30-day Notice
S009 2007-07-02 Normal 180 Day Track No User Fee
S008 2006-09-19 Special (immediate Track)
S007 2006-05-04 Special (immediate Track)
S006 2006-05-02 135 Review Track For 30-day Notice
S005
S004 2006-02-23 Normal 180 Day Track No User Fee
S003 2005-11-21 Special (immediate Track)
S002 2005-11-10 Special (immediate Track)
S001 2005-09-02 135 Review Track For 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.